Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-10-044187)

Filing Details

Accession Number:: 0001209191-10-044187
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-08-27 14:22:33
Reporting Period:: 2010-08-25

Filing Date:: 2010-08-27
Accepted Time:: 2010-08-27 14:22:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
901219	Human Genome Sciences Inc	HGSI	In Vitro & In Vivo Diagnostic Substances (2835)	223178468

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1191231	H James Davis	14200 Shady Grove Road Rockville MD 20850	Exec. Vp, Gen Counsel & Sec.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-08-25	26,000	$9.35	114,739	No	4	M	Direct
Common Stock	Disposition	2010-08-25	2,195	$28.01	112,544	No	4	S	Direct
Common Stock	Disposition	2010-08-25	23,805	$28.00	88,739	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option - Right to Buy	Disposition	2010-08-25	26,000	$0.00	26,000	$9.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2012-12-11	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Chales Schwab effective 5/14/10.
These options have vested and are excercisable.